Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ephedrine/Caffeine Combos Safer Than Ephedrine Alone - Researcher

This article was originally published in The Tan Sheet

Executive Summary

Combining ephedrine alkaloids with caffeine may actually diminish the potential adverse effects of taking ephedrine alone, suggested Arne Astrup, MD/PhD, University of Copenhagen, Denmark, at a Public Health Service meeting on the safety of ephedra supplements.

You may also be interested in...



Ephedrine Alkaloid Sensitivity Study Urged By Researchers Boozer, Daly

A large, case-control study may be necessary to determine whether some people have unusually high sensitivity to the potential adverse effects of ephedrine alkaloids, researchers say in the May issue of the International Journal of Obesity

Ephedrine Alkaloid Sensitivity Study Urged By Researchers Boozer, Daly

A large, case-control study may be necessary to determine whether some people have unusually high sensitivity to the potential adverse effects of ephedrine alkaloids, researchers say in the May issue of the International Journal of Obesity

Ephedrine Alkaloid Sensitivity Study Urged By Researchers Boozer, Daly

A large, case-control study may be necessary to determine whether some people have unusually high sensitivity to the potential adverse effects of ephedrine alkaloids, researchers say in the May issue of the International Journal of Obesity

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS091539

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel